Sio Capital Management’s Elevation Oncology ELEV Stock Holding History

Sio Capital Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-876,611	Closed	-$1.67M	–	52
2023 Q1	$1.67M	Buy	876,611 +516,880	+144%	+$667K	0.82%	23
2022 Q4	$342K	Hold	359,731	–	–	0.18%	40
2022 Q3	$406K	Hold	359,731	–	–	0.17%	39
2022 Q2	$504K	Hold	359,731	–	–	0.2%	50
2022 Q1	$907K	Buy	359,731 +109,731	+44%	+$440K	0.37%	50
2021 Q4	$1.5M	Buy	+250,000	New	+$1.73M	0.46%	47

Other funds holding ELEV

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

ExodusPoint Capital Management New York $10.1B AUM 30.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return